Design Mark 98120495
RegisteredDesign Mark
•
Ownership
MS
Owner Name
Type: Organization / Limited Liability Company
Address
126 East Lincoln Avenue
Rahway, NJ 07065
Critical Dates
First Use Date
Apr 16, 2024
Filing Date
Aug 8, 2023
Registration Date
Mar 11, 2025
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory...
Mark Elements
Text Mark
Design Mark 98120495
Category
Trademark
Standard Characters
No
Color Claim
No
Drawing/Image Description
The mark consists of diagonal lines breaking through an oblong shape.
Design Search Codes
26.11.26
Oblongs as carriers for words, letters or designs26.17.01
Bands, straight26.17.06
Bands, diagonalData source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 09:18 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
The design mark consists of diagonal lines breaking through an oblong shape and covers pharmaceutical preparations in International Class 005 for treating various diseases and disorders including bone, cardiovascular, autoimmune, cancer, diabetes, and others, plus anti-bacterials, antibiotics, vaccines, and inhalers; it also spans domestic classes 006, 018, 044, 046, 051, and 052. The mark is owned by Merck Sharp & Dohme LLC of Rahway, New Jersey. It is registered on the Principal Register as of March 11, 2025, with registration number 7725394 and no notable issues or active legal proceedings.
Recent Activity
Filed on August 8, 2023, under intent-to-use basis (later converted to use basis with first use April 16, 2024), the mark was published for opposition on May 7, 2024, and issued a Notice of Allowance on July 2, 2024. A Statement of Use was filed December 5, 2024, accepted February 20, 2025, leading to registration on March 11, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach